Abeona Therapeutics Company Profile (NASDAQ:ABEO)

About Abeona Therapeutics

Abeona Therapeutics logoAbeona Therapeutics, Inc. develops and delivers gene therapy and plasma-based products for rare diseases. The Company's programs include AB0-101 (AAV9 NAGLU) and ABO-102 (scAAV9 SGSH), adeno-associated virus (AAV)-based gene therapies for Sanfilippo syndrome (MPS IIIB and IIIA). It is developing ABO-201 (scAAV9 CLN3) gene therapy for juvenile Batten disease (JBD); and ABO-301 (AAV LK19 FANCC) for Fanconi anemia (FA) disorder using a novel CRISPR/Cas9-based gene editing approach to gene therapy program for rare blood diseases. In addition, the Company is also developing rare plasma protein therapies including SDF Alpha (alpha-1 protease inhibitor) for inherited COPD using its SDF (Salt Diafiltration) ethanol-free process.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: ABEO
  • CUSIP:
Key Metrics:
  • Previous Close: $4.28
  • 50 Day Moving Average: $3.22
  • 200 Day Moving Average: $2.81
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -11.97
  • P/E Growth: 0.00
  • Market Cap: $144.58M
  • Outstanding Shares: 33,545,000
  • Beta: 1.44
Additional Links:
Companies Related to Abeona Therapeutics:

Analyst Ratings

Consensus Ratings for Abeona Therapeutics (NASDAQ:ABEO) (?)
Ratings Breakdown: 3 Buy Ratings
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $12.67 (193.89% upside)

Analysts' Ratings History for Abeona Therapeutics (NASDAQ:ABEO)
Show:
DateFirmActionRatingPrice TargetDetails
8/26/2016FBR & CoReiterated RatingBuy$15.00View Rating Details
8/21/2016Rodman & RenshawReiterated RatingBuy$17.00View Rating Details
8/18/2016Maxim GroupSet Price TargetBuy$6.00View Rating Details
7/20/2015MLV & Co.Initiated CoverageBuy$15.00View Rating Details
6/11/2015Roth CapitalInitiated CoverageBuy$16.00View Rating Details
5/18/2015HC WainwrightInitiated CoverageBuy$15.00View Rating Details
(Data available from 8/27/2014 forward)

Earnings

Earnings History for Abeona Therapeutics (NASDAQ:ABEO)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/15/2016        
8/16/2016Q2($0.14)($0.20)ViewN/AView Earnings Details
5/16/2016Q1($0.13)($0.17)ViewN/AView Earnings Details
3/8/2016Q415($0.07)ViewN/AView Earnings Details
8/20/2015Q215($0.10)($0.16)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Abeona Therapeutics (NASDAQ:ABEO)
Current Year EPS Consensus Estimate: $-0.69 EPS
Next Year EPS Consensus Estimate: $-0.36 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q3 20161($0.17)($0.17)($0.17)
Q4 20161($0.17)($0.17)($0.17)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Abeona Therapeutics (NASDAQ:ABEO)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Abeona Therapeutics (NASDAQ:ABEO)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
7/31/2015Mark J AhnDirectorBuy18,182$5.50$100,001.00View SEC Filing  
1/26/2015Mark J AhnDirectorBuy25,000$4.00$100,000.00View SEC Filing  
12/24/2014Steven H RouhandehDirectorBuy250,000$4.00$1,000,000.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Abeona Therapeutics (NASDAQ:ABEO)
DateHeadline
4-traders.com logoABEONA THERAPEUTICS INC. : Entry into a Material Definitive Agreement, Financial Statements and Exhibits (form 8-K) (NASDAQ:ABEO)
www.4-traders.com - August 27 at 8:02 AM
biz.yahoo.com logoABEONA THERAPEUTICS INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exh (NASDAQ:ABEO)
biz.yahoo.com - August 27 at 8:02 AM
finance.yahoo.com logoABEONA THERAPEUTICS INC. Financials (NASDAQ:ABEO)
finance.yahoo.com - August 23 at 3:14 PM
capitalcube.com logoETF’s with exposure to Abeona Therapeutics, Inc. : August 19, 2016 (NASDAQ:ABEO)
www.capitalcube.com - August 19 at 3:16 PM
capitalcube.com logoAbeona Therapeutics, Inc. :ABEO-US: Earnings Analysis: Q2, 2016 By the Numbers : August 18, 2016 (NASDAQ:ABEO)
www.capitalcube.com - August 18 at 11:39 AM
seekingalpha.com logoAbeona Therapeutics' (ABEO) CEO Timothy Miller on Q2 2016 Results - Earnings Call Transcript - Seeking Alpha (NASDAQ:ABEO)
seekingalpha.com - August 17 at 8:46 PM
marketwired.com logoAbeona Therapeutics Announces Second Quarter 2016 Financial Results and Recent Clinical Highlights - Marketwired (press release) (NASDAQ:ABEO)
www.marketwired.com - August 16 at 8:34 PM
biz.yahoo.com logoABEONA THERAPEUTICS INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and (NASDAQ:ABEO)
biz.yahoo.com - August 16 at 8:34 PM
4-traders.com logoAbeona Therapeutics : reports 2Q loss (NASDAQ:ABEO)
www.4-traders.com - August 16 at 11:52 AM
sg.finance.yahoo.com logoAbeona Therapeutics reports 2Q loss (NASDAQ:ABEO)
sg.finance.yahoo.com - August 16 at 11:52 AM
publicnow.com logoAbeona Therapeutics Announces Second Quarter 2016 Financial Results and Recent Clinical Highlights (NASDAQ:ABEO)
www.publicnow.com - August 16 at 11:52 AM
biz.yahoo.com logoABEONA THERAPEUTICS INC. Files SEC form 10-Q, Quarterly Report (NASDAQ:ABEO)
biz.yahoo.com - August 15 at 8:48 PM
News IconFormFactor, Palo Alto Networks, Concordia International, Abeona Therapeutics and Proteostasis Therapeutics ... - Yahoo Sports (NASDAQ:ABEO)
sports.yahoo.com - August 12 at 3:15 PM
News IconFormFactor, Palo Alto Networks, Concordia International, Abeona Therapeutics ... (NASDAQ:ABEO)
sports.yahoo.com - August 12 at 11:50 AM
marketwired.com logoAbeona Therapeutics, EB Research Partnership and EB Medical Research Foundation to Collaborate on ... - Marketwired (press release) (NASDAQ:ABEO)
www.marketwired.com - August 11 at 3:16 PM
finance.yahoo.com logoDrug Stocks' Earnings to Watch on Aug 12: CXRX, PTI & ABEO (NASDAQ:ABEO)
finance.yahoo.com - August 11 at 12:11 PM
News IconEB Medical Research Foundation, EB Research Partnership and Abeona Therapeutics Inc. (NASDAQ:ABEO ... - Journal Transcript (NASDAQ:ABEO)
www.journaltranscript.com - August 10 at 11:50 AM
finance.yahoo.com logoAbeona Therapeutics, EB Research Partnership and EB Medical Research Foundation to Collaborate on ... - Yahoo Finance (NASDAQ:ABEO)
finance.yahoo.com - August 10 at 11:50 AM
biz.yahoo.com logoABEONA THERAPEUTICS INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered Sale of Equity (NASDAQ:ABEO)
biz.yahoo.com - August 9 at 8:50 PM
einnews.com logoAbeona Therapeutics, EB Research Partnership and EB Medical Research Foundation to Collaborate on ... - EIN News (press release) (NASDAQ:ABEO)
www.einnews.com - August 9 at 3:14 PM
publicnow.com logoAbeona Therapeutics, EB Research Partnership and EB Medical Research Foundation to Collaborate on Epidermolysis Bullosa (EB) Treatments (NASDAQ:ABEO)
www.publicnow.com - August 9 at 11:58 AM
kcregister.com logoVolatile Stocks: Abeona Therapeutics Inc. (NASDAQ:ABEO), Ball Corporation (NYSE:BLL), Black Hills Corporation ... - KC Register (NASDAQ:ABEO)
www.kcregister.com - August 5 at 3:14 PM
News IconAbeona Therapeutics Announces European Regulatory Approval For Phase 1/2 Gene Therapy Clinical Study For ... - Clinical Leader (NASDAQ:ABEO)
www.clinicalleader.com - August 5 at 3:14 PM
reuters.com logoBRIEF-Abeona Therapeutics gets European regulatory approval for early stage gene therapy clinical study - Reuters (NASDAQ:ABEO)
www.reuters.com - August 4 at 3:17 PM
streetinsider.com logoAbeona Therapeutics (ABEO) Receives European Approval for ABO-102 Phase 1/2 in MPS 2A - StreetInsider.com (NASDAQ:ABEO)
www.streetinsider.com - August 4 at 3:17 PM
streetinsider.com logoAbeona Therapeutics (ABEO) Receives European Approval for ABO-102 Phase 1/2 in MPS 2A (NASDAQ:ABEO)
www.streetinsider.com - August 4 at 11:46 AM
publicnow.com logoAbeona Therapeutics Announces European Regulatory Approval for Phase 1/2 Gene Therapy Clinical Study for Patients With Sanfilippo Syndrome Type A (MPS IIIA) (NASDAQ:ABEO)
www.publicnow.com - August 4 at 11:46 AM
nasdaq.com logoAbeona Therapeutics (ABEO) in Focus: Stock Up 5.7% in Session - Nasdaq (NASDAQ:ABEO)
www.nasdaq.com - August 3 at 3:15 PM
finance.yahoo.com logoAbeona Therapeutics (ABEO) in Focus: Stock Up 5.7% in Session (NASDAQ:ABEO)
finance.yahoo.com - August 3 at 11:48 AM
reuters.com logoBRIEF-Abeona Therapeutics plans to open two additional clinical sites to test ABO-102 - Reuters (NASDAQ:ABEO)
www.reuters.com - August 2 at 3:15 PM
streetinsider.com logoAbeona Therapeutics (ABEO) Updates on ABO-102 Phase 1/2; Second Patient Enrolled, Treated - StreetInsider.com (NASDAQ:ABEO)
www.streetinsider.com - August 2 at 8:01 AM
finance.yahoo.com logo7:13 am Abeona Therapeutics updates on its ongoing Phase 1/2 trial for ABO-102 (NASDAQ:ABEO)
finance.yahoo.com - August 2 at 8:01 AM
publicnow.com logoAbeona Therapeutics Provides Update on Initial Subjects in Sanfilippo Type A Gene Therapy Trial, Demonstrating Encouraging Early Biopotency Signals (NASDAQ:ABEO)
www.publicnow.com - August 2 at 8:01 AM
capitalcube.com logoETF’s with exposure to Abeona Therapeutics, Inc. : July 26, 2016 (NASDAQ:ABEO)
www.capitalcube.com - July 26 at 12:37 PM
capitalcube.com logoETF’s with exposure to Abeona Therapeutics, Inc. : July 26, 2016 (NASDAQ:ABEO)
www.capitalcube.com - July 26 at 12:37 PM
News IconStock Up Nicely This Week: Abeona Therapeutics Inc. (NASDAQ:ABEO) - TGP (NASDAQ:ABEO)
telanaganapress.com - July 23 at 3:16 PM
fiscalstandard.com logoAbeona Therapeutics Inc. (ABEO) Current Analyst Ratings - Fiscal Standard (NASDAQ:ABEO)
www.fiscalstandard.com - July 21 at 3:16 PM
News IconAnalysts' Updated EPS Estimates for July, 20th (ABEO, AGESY, AIQUY, ... (NASDAQ:ABEO)
www.topix.com - July 20 at 9:48 PM
News IconStock Moving Lower for the Month; Investor Update on Abeona Therapeutics Inc. (NASDAQ:ABEO) - Engelwood Daily (NASDAQ:ABEO)
www.engelwooddaily.com - July 20 at 11:23 AM
News IconHeightened Volatility Spotted on Shares of: Abeona Therapeutics Inc. (NASDAQ:ABEO) - Engelwood Daily (NASDAQ:ABEO)
www.engelwooddaily.com - July 19 at 8:41 PM
News IconStock Ticking Higher in Trading: Abeona Therapeutics Inc. (NASDAQ:ABEO) - TGP (NASDAQ:ABEO)
telanaganapress.com - July 19 at 8:41 PM
News IconTrading Action Review: Watching Unusual Volume on Abeona Therapeutics Inc. (NASDAQ:ABEO) - Engelwood Daily (NASDAQ:ABEO)
www.engelwooddaily.com - July 19 at 8:41 PM
News IconAbeona Therapeutics Incorporated (NASDAQ:ABEO) Short Interest Decreased By 35.19% - Press Telegraph (NASDAQ:ABEO)
presstelegraph.com - July 19 at 9:28 AM
finance.yahoo.com logoINVESTOR ALERT: Levi & Korsinsky, LLP Announces the Commencement of an Investigation Into Possible Violations of Delaware Law by Certain Officers and Directors of Abeona Therapeutics Inc. - ABEO (NASDAQ:ABEO)
finance.yahoo.com - July 18 at 2:15 PM
fiscalstandard.com logoAbeona Therapeutics Inc. (ABEO) Broker Price Targets For The Coming Week - Fiscal Standard (NASDAQ:ABEO)
www.fiscalstandard.com - July 18 at 8:04 AM
News IconAbeona Therapeutics Incorporated (NASDAQ:ABEO) Sellers Covered 4.03% of Their Shorts - Press Telegraph (NASDAQ:ABEO)
presstelegraph.com - July 16 at 3:16 PM
News IconInvestor News: Abeona Therapeutics Inc (NASDAQ:ABEO) under Investigation over possible Wrongdoing - GroundReport (NASDAQ:ABEO)
www.groundreport.com - July 13 at 3:18 PM
News IconInvestor News: Abeona Therapeutics Inc (NASDAQ:ABEO) under Investigation over possible Wrongdoing (NASDAQ:ABEO)
www.groundreport.com - July 13 at 11:21 AM
News IconAre Analysts Bullish Abeona Therapeutics Inc (NASDAQ:ABEO) After Last Week? - Press Telegraph (NASDAQ:ABEO)
presstelegraph.com - July 10 at 8:03 AM
News IconAbeona Therapeutics Incorporated (NASDAQ:ABEO) Shorted Shares Decreased By 4.03% - Press Telegraph (NASDAQ:ABEO)
presstelegraph.com - July 9 at 3:16 PM

Social

Abeona Therapeutics (NASDAQ:ABEO) Chart for Saturday, August, 27, 2016


Last Updated on 8/27/2016 by MarketBeat.com Staff